Relevant models of neurological pathologies where IND-NGF efficacy has been attempted include cerebral ischemia, AD, traumatic brain and spinal cord injuries, epilepsy, amyotrophic lateral sclerosis, hypogonadism related to premature aging, and depression. This evidence concerns the gene NGF and hypogonadism.